Pediatric shopping-cart-related injuries treated in US emergency departments, 1990-2011

Keith J Martin1, Thiphalak Chounthirath, Huiyun Xiang

  • 11Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.

Clinical Pediatrics
|December 20, 2013
PubMed

Insights

The 2004 US shopping cart safety standard did not reduce child injuries. Head injuries, including concussions, significantly increased post-standard, indicating a need for better prevention strategies for shopping cart safety.

Area of Science:

  • Public Health
  • Pediatric Safety
  • Injury Prevention

Background:

  • Shopping cart-related injuries pose a significant risk to children.
  • Previous safety standards may not have adequately addressed injury mechanisms.

Purpose of the Study:

  • To evaluate the impact of the 2004 US shopping cart safety standard on pediatric injuries.
  • To analyze trends in shopping cart-related injuries before and after the 2004 standard.

Main Methods:

  • Retrospective analysis of data from the National Electronic Injury Surveillance System (NEISS).
  • Inclusion of data from 1990 to 2011, covering children younger than 15 years.
  • Focus on injury demographics, body regions, and specific injury types like concussions.

Main Results:

  • An estimated 530,494 children <15 years were treated for shopping cart injuries (1990-2011).
  • Head injuries were most common (78.1%).
  • Annual concussion/closed head injury rates increased by 213.3% (0.64 to 2.02 per 10,000 children) from 1990 to 2011, despite the 2004 safety standard.

Conclusions:

  • The 2004 US shopping cart safety standard has not effectively reduced overall shopping cart-related injuries in children.
  • There has been a concerning rise in head injuries, particularly concussions, among children using shopping carts.
  • Enhanced prevention efforts are crucial to mitigate the ongoing risk of shopping cart injuries in pediatric populations.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K